Platinum Investment Management’s Aura Biosciences AURA Stock Holding History

Platinum Investment Management’s Portfolio AURA Stock Details AURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$748K	Hold	111,865	–	–	0.19%	85
2025 Q4	$610K	Sell	111,865 -23,537	-17%	-$140K	0.14%	89
2025 Q3	$837K	Hold	135,402	–	–	0.05%	89
2025 Q2	$848K	Sell	135,402 -26,956	-17%	-$158K	0.06%	79
2025 Q1	$951K	Hold	162,358	–	–	0.06%	73
2024 Q4	$1.33M	Hold	162,358	–	–	0.08%	70
2024 Q3	$1.45M	Hold	162,358	–	–	0.07%	74
2024 Q2	$1.23M	Sell	162,358 -17,787	-10%	-$130K	0.05%	77
2024 Q1	$1.41M	Hold	180,145	–	–	0.06%	80
2023 Q4	$1.6M	Buy	+180,145	New	+$1.53M	0.06%	86

Other funds holding AURA

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MVM

Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Platinum Investment Management's AURA Position: Q1 2026 in Review

Platinum Investment Management held its Aura Biosciences (AURA) position steady in Q1 2026 at 111,865 shares worth $748K. The position accounts for 0.19% of the portfolio, ranked #85.

Platinum Investment Management first reported a position in AURA in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.6M in Q4 2023. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

Platinum Investment Management held 111,865 shares of Aura Biosciences worth $748K as of Q1 2026.
Platinum Investment Management left its Aura Biosciences share count unchanged in Q1 2026.
Aura Biosciences made up 0.19% of Platinum Investment Management's portfolio in Q1 2026, its #85 holding.
Platinum Investment Management first reported a position in Aura Biosciences in Q4 2023 and has held it in 10 quarters since.
Platinum Investment Management's Aura Biosciences position peaked at $1.6M in Q4 2023.
126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Platinum Investment Management's 13F filing for Q1 2026, filed 14 May 2026.